MMR deficient undifferentiated/dedifferentiated endometrial carcinomas showing significant programmed death ligand-1 expression (sp 142) with potential therapeutic implications.
CONCLUSIONS: PD-L1 and PD-1 were expressed in majority of MMR-deficient UEAC /DEAC cases. PD-L1 was not expressed in MMR-proficient carcinomas. These findings might help support potential immunotherapy trials in MMR-deficient UEAC /DEAC.
PMID: 31353229 [PubMed - as supplied by publisher]
Source: Pathology, Research and Practice - Category: Pathology Authors: Hacking S, Jin C, Komforti M, Liang S, Nasim M Tags: Pathol Res Pract Source Type: research
More News: Cancer | Cancer & Oncology | Cancer of the Uterus | Carcinoma | Endometrial Cancer | Gastroschisis Repair | Immunotherapy | Pathology | Science | Statistics | Study | Undifferentiated Carcinoma